Abbott Acquires A Future For Its Diabetes Care Business; Where’s Bayer?
This article was originally published in The Gray Sheet
Executive Summary
Access to a development partnership with insulin infusion pump manufacturer Smiths Medical could prove a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense